The 19 most recent market catalysts affecting $AHR, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.
Sep 3, 2026
Corporate Catalyst
Bullish
Impact 75
American Healthcare REIT Acquires 8 Class A Senior Housing Communities For Approximately $696M, Establishing A New Operating Relationship With LCB Senior Living And A Substantial Presence In Supply-constrained East Coast Markets
American Healthcare REIT (AHR) has announced the acquisition of eight senior housing communities for $696 million, a move that significantly expands its footprint in desirable East…
Sep 2, 2026
Corporate Catalyst
Neutral
Impact 55
American Healthcare REIT Announces Brian Peay To Retire As CFO Effective September 30, 2026
American Healthcare REIT (AHR) has announced that its current CFO, Brian Peay, will retire on September 30, 2026, and Aric Chang will take over the role. This is a planned leadersh…
Sep 2, 2026
Corporate Catalyst
Neutral
Impact 55
American Healthcare REIT Appoints Aric Chang As CFO Effective On October 1, 2026
The appointment of a new CFO, Aric Chang, for American Healthcare REIT (AHR) is a corporate catalyst. While a CFO change can sometimes signal a shift in financial strategy or a res…
Sep 2, 2026
Corporate Catalyst
Bullish
Impact 55
Scotiabank Maintains Sector Outperform on American Healthcare REIT, Raises Price Target to $62
Scotiabank analyst Nicholas Yulico has maintained a 'Sector Outperform' rating on American Healthcare REIT (AHR) and raised its price target from $56 to $62. This action signals in…
Aug 31, 2026
Corporate Catalyst
Bullish
Impact 55
Barclays Maintains Overweight on American Healthcare REIT, Raises Price Target to $66
Barclays analyst Richard Hightower has maintained an 'Overweight' rating on American Healthcare REIT (AHR) and raised the price target from $61 to $66. This action signals continue…
Aug 19, 2026
Corporate Catalyst
Bullish
Impact 65
Keybanc Maintains Overweight on American Healthcare REIT, Raises Price Target to $68
Keybanc analyst Austin Wurschmidt maintained an 'Overweight' rating on American Healthcare REIT (AHR) and raised the price target from $58 to $68. This action signals increased con…
Aug 14, 2026
Corporate Catalyst
Bullish
Impact 55
Truist Securities Maintains Buy on American Healthcare REIT, Raises Price Target to $61
Truist Securities analyst Michael Lewis has raised the price target for American Healthcare REIT (AHR) from $57 to $61 while maintaining a 'Buy' rating. This action indicates incre…
Aug 14, 2026
Corporate Catalyst
Bullish
Impact 55
RBC Capital Maintains Outperform on American Healthcare REIT, Raises Price Target to $61
RBC Capital's analyst Michael Carroll has raised the price target for American Healthcare REIT (AHR) from $56 to $61 while maintaining an 'Outperform' rating. This action signals i…
Aug 13, 2026
Corporate Catalyst
Bullish
Impact 60
Citigroup Maintains Buy on American Healthcare REIT, Raises Price Target to $65
Citigroup analyst Nick Joseph has maintained a 'Buy' rating on American Healthcare REIT (AHR) and raised the price target from $55 to $65. This action signals increased confidence …
Aug 11, 2026
Corporate Catalyst
Bearish
Impact 85
American Healthcare REIT shares are trading lower after the company announced the pricing of its $712.2 million offering of 13.25 shares.
The announcement of a $712.2 million offering of 13.25 shares by American Healthcare REIT is a significant corporate catalyst. The immediate impact is negative for existing shareho…
Aug 11, 2026
Corporate Catalyst
Neutral
Impact 75
Reported Earlier, American Healthcare REIT Prices Public Offering Of 13.25M Shares, Expects ~$712.2M In Gross Proceeds
This public offering by American Healthcare REIT (AHR) is a significant corporate catalyst, as it involves a substantial capital raise of approximately $712.2 million. While the in…
Aug 10, 2026
Corporate Catalyst
Neutral
Impact 75
American Healthcare REIT Announces 13.25M-Share Underwritten Public Offering
The 13.25M-share underwritten public offering by American Healthcare REIT (AHR) is a significant corporate action. While it provides the company with substantial capital, likely fo…
Aug 7, 2026
Corporate Catalyst
Bullish
Impact 75
American Healthcare REIT shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY26 FFO guidance above estimates.
This headline is a significant corporate catalyst for American Healthcare REIT (AHR), directly impacting its share price positively due to strong financial performance and an optim…
Aug 6, 2026
Corporate Catalyst
Bullish
Impact 75
American Healthcare REIT Raises FY2026 FFO Guidance from $2.03-$2.09 to $2.15-$2.19 vs $2.05 Est
American Healthcare REIT (AHR) has announced a significant upward revision to its FY2026 Funds From Operations (FFO) guidance. The new range of $2.15-$2.19 is notably higher than b…
Aug 6, 2026
Corporate Catalyst
Bullish
Impact 92
American Healthcares Q2 FFO $0.54 Beats $0.50 Estimate, Sales $674.250M Beat $663.164M Estimate
American Healthcares (AHR) delivered a significant beat on both its Q2 FFO per share and sales figures, surpassing analyst consensus estimates by 8% and 1.67% respectively. This st…
Jul 27, 2026
Corporate Catalyst
Bullish
Impact 60
Citizens Maintains Market Outperform on American Healthcare REIT, Raises Price Target to $65
Citizens analyst Aaron Hecht maintained a 'Market Outperform' rating on American Healthcare REIT (AHR) and raised the price target from $60 to $65. This action signals increased co…
Jul 22, 2026
Corporate Catalyst
Bullish
Impact 75
American Healthcare REIT Appoints Jeff Hanson CEO, Promotes COO Gabe Willhite To Additional Role Of President,
American Healthcare REIT (AHR) has announced a leadership reshuffle, with Jeff Hanson taking over as CEO while retaining his Chairman role, and Gabe Willhite being promoted to Pres…
Jul 21, 2026
Corporate Catalyst
Neutral
Impact 65
Compass Point Initiates Coverage On American Healthcare REIT with Buy Rating, Announces Price Target of $70
Compass Point has initiated coverage on American Healthcare REIT (AHR) with a 'Buy' rating and a $70 price target. This event is significant because new analyst coverage, especiall…
Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.